Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation

Published on December 30, 2024

if approved; the Company’s anticipated capital requirements, including the amount of capital required for the continued commercialization of

Continue reading on website
Other news

2 ETFs That Are Good Bets to Beat the S&P 500 in 2025

December 30, 2024
is a no-brainer investment to own. Heading into 2025, the ETF is likely to keep up its winning ways.2. Financial Select Sector SPDR Fund

Amplify ETFs Declares December Income Distributions for its Income ETFs

December 30, 2024
as of 11/30/2024). Amplify ETFs deliver expanded investment opportunities for investors seeking growth, income, and risk-managed strategies